December 2022

Getty 23% of Black Americans age 70 and older live with Alzheimer’s disease in america, in response to Alzheimer’s Association. They’re also twice as likely as older whites to have a type of dementia.  A latest study that pulled data from 5.6 million AA and non-Hispanic European Americans found that a latest prescription hypertension drug, telmisartan, could lower the chance of Alzheimer’s in Black adults over 60. The research was conducted by Dr. Feixiong Cheng at his laboratory at Cleveland Clinic’s Genomic Medicine Institute, and the outcomes are published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. “Considering race-specific drug responses holds potential for drastically improving patient care. Identifying these candidate drugs also can reveal more information in regards to the...